Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.

Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.

Item
http://www.wikidata.org/entity/Q40423956
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapyZebrafish as a model system to screen radiation modifiers.Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.Effects of amifostine in combination with cyclophosphamide on female reproductive system.Examination of the effect of ovarian radiation injury induced by hysterosalpingography on ovarian proliferating cell nuclear antigen and the radioprotective effect of amifostine: an experimental study.
P2860

Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.

Item
http://www.wikidata.org/entity/Q40423956
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Protection of normal tissues f ...... WR-2721): preclinical aspects.
@en
type
label
Protection of normal tissues f ...... WR-2721): preclinical aspects.
@en
prefLabel
Protection of normal tissues f ...... WR-2721): preclinical aspects.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P5875
P698
P921
P356
P1433
P1476
Protection of normal tissues f ...... WR-2721): preclinical aspects.
@en
P2093
P304
P31
P356
10.1016/0959-8049(95)00145-9
P478
P577
P5875
P698
P921